Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00268450
Status:
TERMINATED
Last Update Posted:
2018-07-12
First Post:
2005-12-20
Brief Title:
Cisplatin Bevacizumab and Gemcitabine Followed by Surgery Bevacizumab and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Organization Data
Organization:
Medical University of South Carolina
Class:
OTHER
Study ID:
CDR0000454937
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medical University of South Carolina
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None